Igcool Oral Suspension is a combination antacid formulation containing Magaldrate 400 mg and Simethicone 20 mg per dose, designed to provide effective relief from symptoms associated with hyperacidity and gastrointestinal discomfort. Magaldrate acts as a fast-acting antacid by neutralizing excess gastric acid, thereby alleviating heartburn, acid indigestion, and gastritis. Simethicone, an anti-foaming agent, facilitates the reduction of bloating and flatulence by decreasing surface tension of gas bubbles in the gastrointestinal tract, promoting their coalescence and easier expulsion. This dual-action suspension offers symptomatic relief from conditions such as dyspepsia, gastroesophageal reflux disease (GERD), and functional dyspepsia. Igcool Oral Suspension is suitable for use in adults and children above a specified age, providing rapid onset of action with a favorable safety profile when used as directed. It is recommended to administer the suspension after meals and at bedtime or as advised by a healthcare professional. Caution is advised in patients with renal impairment or those on concomitant medications that may interact with antacids. Overall, Igcool Oral Suspension is an effective therapeutic option for managing acid-related gastrointestinal symptoms and associated discomfort.